Stevanato Prodotti E Lavori Speciali S.R.L.

Stevanato Prodotti E Lavori Speciali S.R.L. company information, Employees & Contact Information

STEVANATO Prodotti e lavori speciali è un’azienda che oggi vanta una posizione di leadership nei lavori speciali in campo edile, operando con alti livelli di qualità nei propri cantieri. L’attività, nata nel 1979, era orientata inizialmente alle opere di risanamento e consolidamento delle murature, prevalentemente nel centro storico di Venezia, un ambiente critico che più di altri ha permesso a Stevanato di acquisire conoscenze sempre più specifiche. Dopo anni di esperienza nel settore dei risanamenti e consolidamenti, Stevanato ha allargato il suo campo anche nella demolizione e nel taglio del cemento armato. Durante l’ultimo decennio si è specializzata nell’arresto delle infiltrazioni d’acqua causati dai dissesti statici delle strutture edilizie e dai dissesti idrogeologici dei terreni. Sempre con la massima professionalità che la contraddistingue, oggi Stevanato vanta una posizione di leadership nel settore edile dei lavori speciali.
Looking for a particular Stevanato Prodotti E Lavori Speciali S.R.L. employee's phone or email?

Stevanato Prodotti E Lavori Speciali S.r.l. Questions

News

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings - Stevanato Group

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings Stevanato Group

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. - Stevanato Group

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. Stevanato Group

Stevanato Group to Participate in Upcoming Investor Conferences - Stevanato Group

Stevanato Group to Participate in Upcoming Investor Conferences Stevanato Group

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025 - Stevanato Group

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025 Stevanato Group

EZ-fill Smart®: enhanced RTU Vial Platform - Stevanato Group

EZ-fill Smart®: enhanced RTU Vial Platform Stevanato Group

Subcontractor sues for nearly $1.6M in unpaid work on Stevanato site in Fishers - Inside INdiana Business

Subcontractor sues for nearly $1.6M in unpaid work on Stevanato site in Fishers Inside INdiana Business

Stevanato: Recovery Underway, Buy Confirmed (NYSE:STVN) - Seeking Alpha

Stevanato: Recovery Underway, Buy Confirmed (NYSE:STVN) Seeking Alpha

Stevanato: Expansion In Italy And The U.S. Will Pave The Way (NYSE:STVN) - Seeking Alpha

Stevanato: Expansion In Italy And The U.S. Will Pave The Way (NYSE:STVN) Seeking Alpha

Stevanato Group Reports Financial Results for the Third Quarter of 2024 - Stevanato Group

Stevanato Group Reports Financial Results for the Third Quarter of 2024 Stevanato Group

Advanced Cartridge Systems for Pharmaceutical Applications - Stevanato Group

Advanced Cartridge Systems for Pharmaceutical Applications Stevanato Group

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 - Stevanato Group

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 Stevanato Group

Stevanato Group to Present at Upcoming Investor Conferences - Stevanato Group

Stevanato Group to Present at Upcoming Investor Conferences Stevanato Group

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan - Stevanato Group

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan Stevanato Group

Stevanato Group Reports Financial Results for the First Quarter of 2024 - Stevanato Group

Stevanato Group Reports Financial Results for the First Quarter of 2024 Stevanato Group

Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth - Stevanato Group

Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth Stevanato Group

Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results - Stevanato Group

Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results Stevanato Group

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products - Stevanato Group

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products Stevanato Group

Stevanato Group Reports Financial Results for the Second Quarter of 2024 - Stevanato Group

Stevanato Group Reports Financial Results for the Second Quarter of 2024 Stevanato Group

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges - Stevanato Group

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges Stevanato Group

Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma - Stevanato Group

Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma Stevanato Group

Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense - Stevanato Group

Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense Stevanato Group

Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing - Stevanato Group

Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing Stevanato Group

Stevanato Group: planned investments under the 2020-2023 industrial plan – about 400 million euros to finance the company development - Stevanato Group

Stevanato Group: planned investments under the 2020-2023 industrial plan – about 400 million euros to finance the company development Stevanato Group

Stevanato Group Announces Pricing of Initial Public Offering - Stevanato Group

Stevanato Group Announces Pricing of Initial Public Offering Stevanato Group

Stevanato Group partners with Microsoft: Cloud Computing and Remote Assistance to meet the challenges of the Pharmaceutical Industry - Stevanato Group

Stevanato Group partners with Microsoft: Cloud Computing and Remote Assistance to meet the challenges of the Pharmaceutical Industry Stevanato Group

Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device - Stevanato Group

Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device Stevanato Group

Stevanato Group launches US Technology Excellence Center in Boston - Stevanato Group

Stevanato Group launches US Technology Excellence Center in Boston Stevanato Group

Drug Containment Solutions: Advanced Pharmaceutical Solutions for Injectable Drugs - Stevanato Group

Drug Containment Solutions: Advanced Pharmaceutical Solutions for Injectable Drugs Stevanato Group

Stevanato Group Initiates Construction on New U.S. Facility - Stevanato Group

Stevanato Group Initiates Construction on New U.S. Facility Stevanato Group

2R Vials and Deep Cold Storage - Determining Mechanical & CCI performances - Stevanato Group

2R Vials and Deep Cold Storage - Determining Mechanical & CCI performances Stevanato Group

Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector - Stevanato Group

Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector Stevanato Group

Stevanato Group announces product development collaboration withCambridge Design Partnership on pen-injector technology - Stevanato Group

Stevanato Group announces product development collaboration withCambridge Design Partnership on pen-injector technology Stevanato Group

Stevanato Group expands and consolidates its plastic component and device operations in California. - Stevanato Group

Stevanato Group expands and consolidates its plastic component and device operations in California. Stevanato Group

Presentations - Stevanato Group

Presentations Stevanato Group

Stevanato Group and Bexson Biomedical announce collaboration to develop a customized wearable ketamine delivery device - Stevanato Group

Stevanato Group and Bexson Biomedical announce collaboration to develop a customized wearable ketamine delivery device Stevanato Group

Analyst Coverage - Stevanato Group

Analyst Coverage Stevanato Group

Stevanato Group announces collaboration between Ompi and Westfor the supply of Ompi EZ-fill® Vials for West Ready Pack - Stevanato Group

Stevanato Group announces collaboration between Ompi and Westfor the supply of Ompi EZ-fill® Vials for West Ready Pack Stevanato Group

Stevanato Group signs an agreement with CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development - CEPI

Stevanato Group signs an agreement with CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development CEPI

Stevanato Group brings former CEO back to corner office - Drug Delivery Business

Stevanato Group brings former CEO back to corner office Drug Delivery Business

New corporate identity for Stevanato Group in line withthe company's growth and international expansion objectives - Stevanato Group

New corporate identity for Stevanato Group in line withthe company's growth and international expansion objectives Stevanato Group

Stevanato commits to paying Fishers employees a living wage - Inside INdiana Business

Stevanato commits to paying Fishers employees a living wage Inside INdiana Business

Stevanato Group to Participate in Upcoming Investor Conferences - Business Wire

Stevanato Group to Participate in Upcoming Investor Conferences Business Wire

Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization - Business Wire

Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization Business Wire

Stevanato Group Appoints New CEO - Healthcare Packaging

Stevanato Group Appoints New CEO Healthcare Packaging

Stevanato Group acquires 65% of the Danish SVM Automatikand strengthens its leadership in the Engineering Systems division - Stevanato Group

Stevanato Group acquires 65% of the Danish SVM Automatikand strengthens its leadership in the Engineering Systems division Stevanato Group

Stevanato: Ramping Syringe Demand, Buy Confirmed (NYSE:STVN) - Seeking Alpha

Stevanato: Ramping Syringe Demand, Buy Confirmed (NYSE:STVN) Seeking Alpha

Stevanato Group acquires InnoScan - Stevanato Group

Stevanato Group acquires InnoScan Stevanato Group

Stevanato Group develops disposable pen injector for pharmaceutical treatments - Packaging Europe

Stevanato Group develops disposable pen injector for pharmaceutical treatments Packaging Europe

STVN IPO News - Italian drug vial supplier Stevanato Group prices downsized US IPO at $21 low end - renaissancecapital.com

STVN IPO News - Italian drug vial supplier Stevanato Group prices downsized US IPO at $21 low end renaissancecapital.com

STEVANATO GROUP ACQUIRES OPERATING UNITS OF BALDA GROUP - Stevanato Group

STEVANATO GROUP ACQUIRES OPERATING UNITS OF BALDA GROUP Stevanato Group

Stevanato Group Announces Expansion of Corporate Headquarters - Business Wire

Stevanato Group Announces Expansion of Corporate Headquarters Business Wire

Stevanato IPO raises $672M to fund biologics, vaccine delivery - Fierce Pharma

Stevanato IPO raises $672M to fund biologics, vaccine delivery Fierce Pharma

Top Stevanato Prodotti E Lavori Speciali S.R.L. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant